Emerging evidence supports the important biologic role of CDK1 in controlling the cell cycle in many cancers, and the complexes of CDK1 with cyclin A and cyclin B are sufficient to drive cancer cell cycle progression via the phosphorylation of hundreds of proteins at multiple sites [13,41]. Here, CCNA2 is linked to cancer.